Skip to content
  • Monday, 26 October 2026
  • 2:21 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • The decline in United States drug overdose deaths is not driven by increased naloxone use according to new research
Environmental & Analytical Chemistry

The decline in United States drug overdose deaths is not driven by increased naloxone use according to new research

Abdurrohim Arsyad Oct 26, 2026 0

The landscape of the American opioid crisis shifted dramatically between mid-2023 and the end of 2025, a period defined by…

Read More
Quintessence Biotech Unveils Groundbreaking Artificial Cell Technology to Revolutionize Cell and Gene Therapy ManufacturingScience News: A Century of Empowering Public Understanding of ScienceImmunai’s Digital "Plumbing" Secures Third Expansion with AstraZeneca, Deepening AI Integration Across Clinical PipelineBreakthrough Brain Imaging Study Links Long COVID to Dopamine Neuron Damage
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule IThe decline in United States drug overdose deaths is not driven by increased naloxone use according to new researchESMO 2026: GSKs mo rez seeks an edge in a crowded adc field in ovarian cancerThe Biological Mystery of Lilliputian Hallucinations and the Discovery of a Mysterious Mushroom Species
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I
Lana Keisha Oct 26, 2026
Environmental & Analytical Chemistry
The decline in United States drug overdose deaths is not driven by increased naloxone use according to new research
Abdurrohim Arsyad Oct 26, 2026
Pharmaceutical R&D
ESMO 2026: GSKs mo rez seeks an edge in a crowded adc field in ovarian cancer
Teuku Ryan Oct 26, 2026
Molecular & Cell Biology
The Biological Mystery of Lilliputian Hallucinations and the Discovery of a Mysterious Mushroom Species
Angie Faith Oct 26, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ